AP News·3 min read·medium
New flu vaccine mFlusiva is approved for older people
L
Lauran Neergaard✦AI Summary
The FDA has approved Moderna's new mRNA-based flu vaccine, mFlusiva, for adults aged 50 and older. This marks the first time mRNA technology, previously used for COVID-19, has been applied to a flu vaccine to potentially improve efficacy and manufacturing speed.
Add AP News as your preferred source to see more of our stories on Google. --> Share
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in